Kidney cancer progressed after immunotherapy? 🧬
FDA approved belzutifan (Welireg®) + lenvatinib (Lenvima®) on Sept 28 for advanced clear cell RCC after PD-1/PD-L1 therapy: the first HIF-2α inhibitor + VEGFR-TKI combo for these patients.

Kidney cancer progressed after immunotherapy? 🧬
FDA approved belzutifan (Welireg®) + lenvatinib (Lenvima®) on Sept 28 for advanced clear cell RCC after PD-1/PD-L1 therapy: the first HIF-2α inhibitor + VEGFR-TKI combo for these patients.
Overnight hair loss at 12? 😨
On Sept 25, 2026, the FDA approved baricitinib (Olumiant) for patients aged 12+ with severe alopecia areata.
A new option for teens. 🎉
Ever gotten sick while traveling in China and had zero clue where the nearest pharmacy was? 😷 Here's your quick survival guide — from map searches to delivery apps, we've got you covered. 🧵👇
#TravelChina #ChinaTravelTips #ExpatLife #ChinaOnlinePharmacy